ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.00%
US Tech 100
17,941.60
0.59%
다우존스 지수
39,558.11
0.00%
Bitcoin
63,770.60
3.61%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. EyePoint Pharmaceuticals Inc (EYPT)

  7. EyePoint Pharmaceuticals Inc (EYPT) 뉴스

EYPT EyePoint Pharmaceuticals Inc

12.45
0.00 (0.00%)
시간외 단일가
최종 업데이트: 21:39:17
15분 지연
기업명 주식 심볼 시장 주식 타입
EyePoint Pharmaceuticals Inc EYPT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 12.45 21:39:17
개장가 저가 고가 종가 전일 종가
12.45
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/05/202423:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202405:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/05/202420:05EDGAR2Form 8-K - Current report
08/05/202420:00GLOBEEyePoint Pharmaceuticals Reports First Quarter 2024..
06/05/202422:25EDGAR2Form 8-K - Current report
06/05/202420:00GLOBEEyePoint Pharmaceuticals Announces Topline Data from the..
16/04/202420:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
02/04/202420:00GLOBEEyePoint Pharmaceuticals Expands Scientific Advisory Board..
18/03/202420:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
09/03/202403:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/03/202421:05EDGAR2Form 8-K - Current report
07/03/202421:00GLOBEEyePoint Pharmaceuticals Reports Fourth Quarter and..
05/03/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/03/202421:01EDGAR2Form 8-K - Current report
04/03/202421:00GLOBEEyePoint Pharmaceuticals Announces Appointment of Ramiro..
29/02/202421:00GLOBEEyePoint Pharmaceuticals to Report Fourth Quarter and..
27/02/202421:00GLOBEEyePoint Pharmaceuticals Announces Participation at Upcoming..
23/02/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202421:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
15/02/202411:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202407:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202402:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/02/202407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/02/202406:20GLOBEEyePoint Pharmaceuticals Announces Two Presentations of..
03/02/202406:22EDGAR2Form 144 - Report of proposed sale of securities
31/01/202421:00GLOBEEyePoint Pharmaceuticals to Present at the Guggenheim..
31/01/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202407:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202408:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:25EDGAR2Form 144 - Report of proposed sale of securities
25/01/202406:17EDGAR2Form 144 - Report of proposed sale of securities
24/01/202406:42EDGAR2Form 144 - Report of proposed sale of securities
24/01/202406:19EDGAR2Form 144 - Report of proposed sale of securities
23/01/202406:19EDGAR2Form 144 - Report of proposed sale of securities
17/01/202408:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/01/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/01/202421:00GLOBEEyePoint Pharmaceuticals Reports Inducement Grants Under..
12/01/202407:33EDGAR2Form 144 - Report of proposed sale of securities
12/01/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202421:05EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
EYPT
EyePoint Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유